Back to search
FDAFDA · Food and drugs·Recall number D-016-2014

PACLITAXEL INJECTION, USP (semisynthetic); 300 mg/50 mL; (6 mg/mL); Multiple Dose Vial;(NDC 63323-763-50); Rx Only; Manufactured for APP Pharmaceuticals, LLC; Schaumburg, IL 60173; Made in India

Published December 4, 2013 · Recall initiated: November 8, 2013

Summary

FDA records drug Class III recall D-016-2014, published December 4, 2013 and initiated November 8, 2013. Recalling firm: Fresenius Kabi USA, LLC; Status: Terminated; Reported quantity: 71,129 vials; Lot: Lot # 871ZA00201, Exp 11/13 Lot # 871ZA00301, Exp 11/13 Lot # 871ZA00302, Exp 11/13 Lot # 871ZA00401, Exp 11/13 Lot # 871ZA00402, Exp 11/13 Lot # 872ZA00101, Exp 12/13 Lot # 872ZA00201, Exp 12/13 Lot # 872ZA00301, Exp 12/13 Lot # 872ZA00401, Exp 12/13 Lot # 872ZA00501, Exp 12/13. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or Missing Package Insert- Missing text on the product insert in the "Clinical Studies" and "Specific Adverse Events" sections.

What to do

Voluntary: Firm initiated · Letter

Get an email if PACLITAXEL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PACLITAXEL
Manufacturer
Fresenius Kabi USA, LLC
Distributor
US: Nationwide and Puerto Rico
UPC
0363323763503
Lot
Lot # 871ZA00201, Exp 11/13 Lot # 871ZA00301, Exp 11/13 Lot # 871ZA00302, Exp 11/13 Lot # 871ZA00401, Exp 11/13 Lot # 871ZA00402, Exp 11/13 Lot # 872ZA00101, Exp 12/13 Lot # 872ZA00201, Exp 12/13 Lot # 872ZA00301, Exp 12/13 Lot # 872ZA00401, Exp 12/13 Lot # 872ZA00501, Exp 12/13
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PACLITAXEL INJECTION, USP (semisynthetic); 300 mg/50 mL; (6 mg/mL); Multiple Dose Vial;(NDC 63323-763-50); Rx Only; Manufactured for APP Pharmaceuticals, LLC; Schaumburg, IL 60173; Made in India recalled?

Yes. FDA published recall D-016-2014 on December 4, 2013. Reported hazard: Labeling: Incorrect or Missing Package Insert- Missing text on the product insert in the "Clinical Studies" and "Specific Adverse Events" sections.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PACLITAXEL. UPC: 0363323763503.